morn deliv beat top bottom-lin ex-fx growth
comfort ex-fx estim driven primarili higher
knee sale model worth note one addit
bill day posit impact overal growth growth encourag
nonetheless manag left fy outlook unchang gave increment color
next year continu expect consist ex-fx top-lin growth
pressur gross margin net modest adj oper margin improv
though could look reinvest applaud progress manag
make improv perform busi remain sidelin
see name attract profil similar valuat level
result top street expect report sale approxim
ex-fx roughli consensu sale upsid quarter
rel expect driven knee hip adjust ep
ahead street
chang fy outlook manag left compani previou guidanc
unchang includ revenu growth report adj ep
adj oper margin adj tax rate
manag note fx becom increment headwind sinc call fx
expect toward high-end guidanc rang
point call deliv good quarter top-lin also drove
y/i adj op margin improv first time sever quarter knee
hip saw sequenti growth acceler encourag
view knee growth strong strength driven multipl factor
one driver rosa knee saw capit sale acceler
level said feedback rosa knee remain posit custom pipelin
continu grow separ compani also spent fair amount time field
question analyst messag top-lin consist durabl
ex-fx growth next year gross margin expect declin due
hand headwind still expect posit gener modest adj op
margin improv manag note howev compani could elect
reinvest margin improv back top-lin support long-term growth
right opportun present
continu next page
signific drop market volum greater-than-expect market share loss
zimmer manufactur market orthoped spine dental implant
price close novemb
ep
debt total capit
piper jaffray seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
stock thought print demonstr continu execut zbh turnaround
strategi laid ceo bryan hanson said remain sidelin time given
valuat outlook busi next year lsd top-lin growth estim
msd adj ep growth maintain neutral rate rais price target
base adj ep estim prior reflect
continu progress
page
 gener incom expens incom incom zimmer tax net incom analysi gross gener oper compani report piper jaffray estim zimmer biomet
million except per share data
good sold
adjust net incom zimmer hold
good sold
percent sale
good sold
current disclosur inform compani locat http //www piperjaffray com/researchdisclosur
